Lifeboat Foundation: Safeguarding Humanity
Toggle light / dark theme

Blog

Category: biotech/medical – Page 1005

It’s all thanks to nanoclusters.

A new nanoscale 3D printing material developed by Stanford University engineers may provide superior structural protection for satellites, drones, and microelectronics.

A dual-phase, nanostructured high-entropy alloy that has been 3D printed by researchers from the University of Massachusetts Amherst and the Georgia Institute of Technology is stronger and more ductile than other cutting-edge additively manufactured materials. This discovery could lead to higher-performance components for use in aerospace, medicine, energy, and transportation.

High entropy alloys (HEAs), as they are called, have gained popularity as a new paradigm in materials science over the past 15 years. They allow for the creation of a nearly limitless number of different alloy designs since they include five or more elements in nearly equal amounts. Brass, carbon steel, stainless steel, and bronze are examples of traditional alloys that mix a principal element with one or more trace elements.

Continue reading “A breakthrough 3D-printed material incredibly strong and ductile” | >

People affected by the lethal glioblastoma cancer only live for 12–18 months after diagnosis.

A global trial that began in 2007 has confirmed that a vaccine for the treatment of the most lethal brain cancer can give patients years of extended life.

Peterschreiber.media/iStock.

“This is a potent molecule that’s very exciting to us in terms of its potential for deployment against glioblastoma,” said Steve Kay, Ph.D., the senior author of the study.

Continue reading “Scientists have just made a breakthrough for a potential glioblastoma drug” | >

“A world without heart attack and stroke” — New video from our 2022 #RejuvenationStartupSummit: Mike Kope, CEO of Corporate Affairs, Cyclarity Therapeutics — prevents age-related conditions such as atherosclerosis, heart attack, and stroke by addressing the root cause. Enjoy!

Mike Kope, CEO of Cyclarity Therapeutics at Rejuvenation Startup Summit 2022.

Connect to Forever Healthy:

Continue reading “Mike Kope at Rejuvenation Startup Summit 2022” | >

“Leveraging a platform to develop therapeutics that render calcified tissue and organs supple again” — New video from our #RejuvenationStartupSummit: Matthias Breugelmans, CEO of Elastrin Therapeutics Inc… Enjoy!

Matthias Breugelmans, CEO of Elastrin Therapeutics at Rejuvenation Startup Summit 2022.

Connect to Forever Healthy:

Continue reading “Matthias Breugelmans at Rejuvenation Startup Summit 2022” | >

By mushrooms…?

People like Nathan have found out first hand that they can. You may have also seen scientists and doctors talking about mycotherapy for serious chronic conditions like cancer and HIV. That’s because many conditions thought of as diseases really have the same cause– an immune system that was unbalanced and compromised by environmental factors or diet.

Certain foods we eat are inflammatory, they boost problematic cells in our body called TH2 cytokines, which cause inflammation, and these cells can cause allergic reactions, auto-immune conditions, and weaken the cancer-fighting TH1 cytokines. When the TH1 cytokines are weakened by inflammatory foods, cancer is allowed to thrive and grow and spread.

But our bodies naturally have the ability to fight diseases and cancers, that’s what our immune system’ does.

The cells responsible for finding and removing cancer in our body, the TH1 cytokines, do this amazingly– but inflammatory foods and environments shut them down and prevent these natural cells from doing their jobs and killing cancerous cells quickly.

Continue reading “MUSHROOMS VS CANCER: Can immune systems fight off cancer when balanced” | >

Patients with a specific form of age-related macular degeneration (AMD), a leading cause of blindness in the United States, are also highly likely to have either underlying heart damage from heart failure and heart attacks, or advanced heart valve disease, or carotid artery disease associated with certain types of strokes, according to a new study from New York Eye and Ear Infirmary of Mount Sinai.

This research, published November 17 in BMJ Open Ophthalmology, is the first to identify which types of high-risk cardiovascular and carotid artery disease are linked to the eye disorder. The findings could prompt increased screening to save vision, diagnose undetected heart disease, and prevent .

“For the first time, we have been able to connect these specific high-risk cardiovascular diseases to a specific form of AMD, the one with subretinal drusenoid deposits (SDDs),” explains lead author R. Theodore Smith, MD, Ph.D., Professor of Ophthalmology at the Icahn School of Medicine at Mount Sinai.

Read more | >

This is the first time scientists have observed vessels form with such a close resemblance to the complicated structure of naturally occurring blood vessels.

An international research collaboration headed by the University of Sydney has created technology that allows for the production of materials that mirror the structure of living blood vessels, with major implications for the future of surgery.

Preclinical research showed that once the manufactured blood vessel was transplanted into mice, the body accepted it and new cells and tissue began to develop in the appropriate locations, thereby converting it into a “living blood vessel.”

Read more | >